For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Alan, 70, was diagnosed with Hodgkin's lymphoma two years after his symptoms started, after doctors struggled to find the ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Dr. Hussein Tawbi, who works for MD Anderson in Houston, said there are two things he hopes people take away from the story ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

A phase II clinical trial is larger and is used to determine if the treatment is effective. Depending on the prevalence of the type of cancer the treatment is designed for, up to 100 patients may ...